Market News

Regeneron (REGN) Stock Declined While Schaper Benz & Wise Investment Counsel Has Boosted Holding by $814,936; As Total S A (TOT) Stock Price Rose, Park Circle Co Has Boosted Holding

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Logo

Peter S. Park increased its stake in Total S A (TOT) by 9.62% based on its latest 2018Q1 regulatory filing with the SEC. Park Circle Co bought 8,900 shares as the company’s stock rose 1.42% while stock markets declined. The hedge fund run by Peter S. Park held 101,400 shares of the energy company at the end of 2018Q1, valued at $5.85 million, up from 92,500 at the end of the previous reported quarter. Park Circle Co who had been investing in Total S A for a number of months, seems to be bullish on the $163.70B market cap company. The stock increased 0.80% or $0.49 during the last trading session, reaching $61.38. About 1.82M shares traded or 4.70% up from the average. TOTAL S.A. (NYSE:TOT) has risen 12.11% since June 14, 2017 and is uptrending. It has underperformed by 0.46% the S&P500. Some Historical TOT News: 16/05/2018 – TOTAL TO LIMIT LA MEDE REFINERY PALM OIL SUPPLY TO 300,000 T/YR; 11/05/2018 – TTA: TOTAL: Algeria: Total Strengthens Its Cooperation with Sonatrach and Launches the Engineering Studies for a Petrochemical; 16/05/2018 – TOTAL CONSIDERS SEEKING U.S. WAIVER FOR IRANIAN GAS PROJECT; 25/05/2018 – TOTAL SA TOTF.PA – TO HAVE OPPORTUNITY TO ACQUIRE 10% TO 15% DIRECT INTEREST IN NOVATEK’S FUTURE LNG PROJECTS IN YAMAL AND GYDAN; 05/03/2018 – TOTAL CEO SAYS SHALE IS NOT ONE OF 5 CORE STRENGTHS FOR CO; 08/03/2018 – AP Moeller-Maersk Completes Sale of Maersk Oil to Total; 28/03/2018 – $FP.FR: BREAKING: EU is considering new sanctions against Iran in response to its ballistic missile program. – ! $FP.FR; 23/05/2018 – Total, Borealis and NOVA Chemicals Close Their Joint Venture in Petrochemicals; 14/03/2018 – Total SA Approves Capital Increase for Employees and Retirees Under Certain Conditions; 13/04/2018 – Total 1Q European Refining Margin $25.6/Ton

Schaper Benz & Wise Investment Counsel Inc increased its stake in Regeneron (REGN) by 18.23% based on its latest 2018Q1 regulatory filing with the SEC. Schaper Benz & Wise Investment Counsel Inc bought 2,369 shares as the company’s stock declined 9.59% with the market. The institutional investor held 15,367 shares of the health care company at the end of 2018Q1, valued at $5.29 million, up from 12,998 at the end of the previous reported quarter. Schaper Benz & Wise Investment Counsel Inc who had been investing in Regeneron for a number of months, seems to be bullish on the $33.22 billion market cap company. The stock decreased 0.40% or $1.25 during the last trading session, reaching $308.28. About 453,207 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 35.54% since June 14, 2017 and is downtrending. It has underperformed by 48.11% the S&P500. Some Historical REGN News: 11/05/2018 – Bayer: Eylea Receives Approval in China; 15/05/2018 – Partner Fund Adds Bristol-Myers, Exits Regeneron: 13F; 11/05/2018 – Bayer: Second Indication for Eylea to Be Approved in China; 21/03/2018 – Regeneron Genetics Center® Publication in New England Journal of Medicine Identifies New Genetic Variant Providing Protection; 11/03/2018 – Umer Raffat set up a call with $MDCO execs tomorrow. Focus is on $ESPR, $MDCO and $AMGN reactions after $REGN and $SNY scored on high-risk PCSK9 study – DON’T MISS:; 10/03/2018 – REG-Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need; 19/03/2018 – EYLEA® (AFLIBERCEPT) INJECTION DEMONSTRATES POSITIVE TOPLINE RESULTS IN PHASE 3 NON-PROLIFERATIVE DIABETIC RETINOPATHY TRIAL; 19/03/2018 – With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell; 16/05/2018 – REG-Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis; 21/03/2018 – ALNYLAM PHARMACEUTICALS INC – ALNYLAM WILL LEVERAGE ITS RNAI THERAPEUTICS PLATFORM TO IDENTIFY COMPOUNDS DIRECTED TO TARGET

Among 33 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 11 have Buy rating, 1 Sell and 21 Hold. Therefore 33% are positive. Regeneron Pharmaceuticals Inc. had 127 analyst reports since July 28, 2015 according to SRatingsIntel. Robert W. Baird downgraded the shares of REGN in report on Tuesday, August 1 to “Underperform” rating. On Monday, August 31 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock has “Buy” rating by Guggenheim on Monday, October 23. BMO Capital Markets maintained Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Monday, October 16 with “Hold” rating. Citigroup upgraded Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday, January 9 to “Hold” rating. Cowen & Co maintained the stock with “Hold” rating in Wednesday, June 21 report. Morgan Stanley maintained it with “Equal-Weight” rating and $490 target in Friday, October 6 report. Credit Suisse upgraded Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Monday, September 18 to “Buy” rating. Guggenheim downgraded the shares of REGN in report on Tuesday, May 1 to “Neutral” rating. The firm has “Hold” rating by BMO Capital Markets given on Thursday, February 8.

Investors sentiment decreased to 1.05 in Q1 2018. Its down 0.12, from 1.17 in 2017Q4. It fall, as 70 investors sold REGN shares while 158 reduced holdings. 71 funds opened positions while 169 raised stakes. 69.33 million shares or 0.23% more from 69.17 million shares in 2017Q4 were reported. Citigroup invested 0.02% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Joel Isaacson Ltd Liability reported 0.18% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Regions Corp invested in 0.01% or 1,588 shares. Polen Ltd Company holds 1.42 million shares. New Mexico Educational Retirement Board invested in 0.1% or 7,300 shares. Clearbridge Invests Limited Liability invested 0.27% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Moreover, Gabelli Funds Limited Liability Company has 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Federated Invsts Pa stated it has 3,456 shares. California Pub Employees Retirement Systems holds 185,868 shares. Bennicas & Assocs holds 0.56% or 1,805 shares. The Pennsylvania-based Riggs Asset Managment Co has invested 0.02% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Kentucky Retirement System holds 0.12% or 4,030 shares. Alliancebernstein Lp reported 220,464 shares. Tekla Mgmt Ltd Liability owns 139,560 shares or 1.87% of their US portfolio. At Bancshares owns 1,598 shares.

Since February 9, 2018, it had 0 buys, and 6 insider sales for $48.41 million activity. 11,407 shares valued at $3.37 million were sold by STAHL NEIL on Wednesday, May 23. 121,601 shares were sold by Sanofi, worth $37.61 million. Shares for $5.72 million were sold by SING GEORGE L.

More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Streetinsider.com which released: “Sanofi (SNY), Regeneron (REGN) Announce NEJM Published Pivotal Cemiplimab Trials showing Positive Results in …” on June 04, 2018, also Fool.com with their article: “Should CRISPR Stock Investors Worry About Cancer?” published on June 13, 2018, Gurufocus.com published: “Stocks That Fell to 3-Year Lows in the Week of May 25” on May 27, 2018. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Seekingalpha.com and their article: “Regeneron Unknown: Eylea Future Competition Effects” published on May 17, 2018 as well as Finance.Yahoo.com‘s news article titled: “The Bull Case for Regeneron Pharmaceuticals Inc Couldn’t Be More Clear” with publication date: June 07, 2018.

Schaper Benz & Wise Investment Counsel Inc, which manages about $585.75M and $675.15M US Long portfolio, decreased its stake in American Express (NYSE:AXP) by 3,487 shares to 153,061 shares, valued at $14.28M in 2018Q1, according to the filing. It also reduced its holding in Sysco (NYSE:SYY) by 8,365 shares in the quarter, leaving it with 303,898 shares, and cut its stake in Intel (NASDAQ:INTC).

More important recent TOTAL S.A. (NYSE:TOT) news were published by: Seekingalpha.com which released: “Total plans petrochemical growth along US Gulf Coast” on June 05, 2018, also Fool.com published article titled: “I Still Can’t Believe Oil Giant Total SA Spent $1.6 Billion on a Utility”, Seekingalpha.com published: “Reuters: European refiners winding down purchases of Iranian oil” on June 06, 2018. More interesting news about TOTAL S.A. (NYSE:TOT) was released by: Seekingalpha.com and their article: “French farmers halt refinery, depot blockades after talks” with publication date: June 13, 2018.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *